Invesco Biotechnology & Genome ETF (PBE) 📈: графики для анализа доходности фонда Invesco Biotechnology & Genome ETF

Kategorie	Aktie, %	Menge
Healthcare	99.92315	30

Austausch	Aktie, %	Menge
NASDAQ	96.67	29
New York Stock Exchange	3.33	1

Land	Menge	Unternehmen
United States	29	Amgen (aktie - 5.18%) United Therapeutics Corporation (aktie - 5.07%) Illumina (aktie - 5.03%) Biogen (aktie - 4.92%) Alnylam Pharmaceuticals, Inc. (aktie - 4.9%) Regeneron (aktie - 4.78%) BioMarin Pharmaceutical (aktie - 3.92%) Neurocrine Biosciences (aktie - 3.89%) Xencor, Inc. (aktie - 3.36%) MannKind Corporation (aktie - 3.36%) Novavax, Inc. (aktie - 3.17%) Protagonist Therapeutics, Inc. (aktie - 3.06%) Bio-Techne Corporation (aktie - 3.02%) Veracyte, Inc. (aktie - 2.98%) TG Therapeutics, Inc. (aktie - 2.92%) Natera, Inc. (aktie - 2.91%) ACADIA Pharmaceuticals Inc. (aktie - 2.87%) Collegium Pharmaceutical, Inc. (aktie - 2.83%) Exelixis (aktie - 2.81%) Catalyst Pharmaceuticals, Inc. (aktie - 2.78%) Myriad Genetics, Inc. (aktie - 2.75%) Incyte (aktie - 2.74%) BioCryst Pharmaceuticals, Inc. (aktie - 2.7%) Blueprint Medicines Corporation (aktie - 2.69%) Repligen Corporation (aktie - 2.68%) Halozyme Therapeutics, Inc. (aktie - 2.56%) CareDx, Inc (aktie - 2.55%) OPKO Health, Inc. (aktie - 2.45%) Vericel Corporation (aktie - 2.38%)
Netherlands	1	Qiagen N.V. (aktie - 2.67%)

Investing Port